Others

Ajanta Pharma Ltd. - Outcome Of Board Meeting

| Updated on July 31, 2019 Published on July 31, 2019

At the Board meeting held today, the Board has inter alia approved and taken on record Unaudited Financial results for the quarter ended 30th June 2019. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following:
i. Press Release being issued on the Results for the quarter ended 30th June 2019;
ii. Unaudited Consolidated Financial Results for the quarter ended 30th June 2019;
iii. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Consolidated Financial Results for the quarter ended 30th June 2019;
iv. Unaudited Standalone Financial Results for the quarter ended 30th June 2019;
v. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Standalone Financial Results for the quarter ended 30th June 2019.

Kindly note that the meeting of the Board of Directors commenced at 2.30 p.m. and concluded at 5.10 p.m. and take the above on your records.

Pdf Link: Ajanta Pharma Ltd. - Outcome Of Board Meeting

Source : BSE - www.bseindia.com

Published on July 31, 2019
This article is closed for comments.
Please Email the Editor